Skip to main content

Table 1 Relationship between HM13 expression and clinical pathological features

From: Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma

Clinicopathological parameter

Case(n)

HM13 expression

χ2

p Value

High

Low/loss

Age (years)

  ≤ 60

27

12

15

0.002

0.957

  > 60

32

14

18

  

Gender

 Male

45

20

25

0.010

0.916

 Female

14

6

8

  

HBV Infection

 Yes

41

19

22

0.281

0.595

 No

18

7

11

  

Recurrence

 Yes

29

17

12

4.901

0.0268

 No

30

9

21

  

TNM Stage

 I &II

42

12

30

14.201

0.0002

 III&IV

17

14

3

  

Grade

 G1 & G2

35

9

26

11.761

0.0006

 G3 & G4

24

17

7

 Â